Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.03.24.644909

Molecular Mechanisms of Chinese Medicine in Regulating Colorectal Cancer Immune Microenvironment: Insights from Single-Cell Transcriptomics and Network Pharmacology

Abstract

BackgroundThe molecular mechanisms underlying the efficacy of Traditional Chinese Medicine (TCM) in colorectal cancer treatment remain largely unexplored. We developed a computational systems biology approach integrating single-cell transcriptomics with network pharmacology to elucidate the potential mechanisms of TCM in modulating colorectal cancer progression. MethodsWe developed an integrated computational pipeline for multi-omics data analysis combining single-cell transcriptomics with network pharmacology. Raw single-cell RNA-seq data from 3 normal tissues and 3 colorectal tumors were obtained from GEO database and processed using a customized workflow in R. Quality control, normalization, and dimensionality reduction were performed using the Seurat v4.0 algorithm, followed by unsupervised clustering to identify cell subpopulations. Differentially expressed genes (DEGs) were identified using MAST algorithm with adjusted p-value < 0.05 and |log2FC| > 1.0. These computationally identified DEGs were subsequently mapped to a comprehensive Traditional Chinese Medicine (TCM) database using a network pharmacology approach to predict herb-target interactions. In parallel, we integrated TCGA RNA-seq data (STAR-counts) with clinical information, applying log2(TPM+1) transformation for normalization. We then implemented a machine learning-based correlation analysis to construct gene-cell-immunity-pathway networks, using weighted gene co-expression network analysis (WGCNA) to identify key regulatory modules. ResultsOur computational analysis of single-cell RNA-seq data identified 109 differentially expressed genes (DEGs) that define the molecular signature of colorectal cancer microenvironment. Clustering algorithms revealed 14 distinct cell subpopulations, with predominant immune cell infiltration, particularly B and T lymphocytes, suggesting a complex immune regulatory network. Network pharmacology analysis mapped these DEGs to potential therapeutic targets, computationally predicting interactions with 140 traditional Chinese herbs. These herbs were classified into 8 functional categories. Through integrative multi-omics analysis and pathway enrichment algorithms, we identified core regulatory networks comprising 23 genes and 39 significantly enriched signaling pathways (FDR < 0.01) that orchestrate immune cell function in the tumor microenvironment. Notably, our analysis in silico revealed previously uncharacterized gene-pathway interactions that may explain the immunomodulatory effects of specific herbal compounds. ConclusionsOur systems biology and computational analysis revealed a potential mechanism by which 8 categories of Chinese herbal medicines and 23 genes across 39 signaling pathways may regulate colorectal cancer progression through modulation of specific gene regulatory networks and immune cell functions. These findings demonstrate the value of integrative computational approaches in elucidating complex biological mechanisms of traditional medicines

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Zhang, C., Zhang, Y., Li, P., Wang, Y., Guo, K.. 2025-03-27. Molecular Mechanisms of Chinese Medicine in Regulating Colorectal Cancer Immune Microenvironment: Insights from Single-Cell Transcriptomics and Network Pharmacology. https://doi.org/10.1101/2025.03.24.644909

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

CTR1-mediated copper uptake orchestrates metabolic-epigenetic regulation of pathogenic TH17 cells in autoimmune disease

Pathogenic T helper 17 (pTH17) cells are a subset of CD4+ T cells driving autoimmune diseases including multiple sclerosis (MS). Compared to homeostatic TH17 cells and other TH subsets, pTH17 have enhanced mitochondrial function and oxidative phosphorylation (OXPHOS) that supports their differentiation and pathogenic function. Here we identify Copper Transporter 1 (CTR1), encoded by Slc31a1, as essential for copper uptake in CD4+ T cells, OXPHOS and pTH17 cell differentiation and function. While copper levels are known to be higher in the cerebrospinal fluid of patients with MS compared to healthy individuals, and excess copper contributes to oligodendrocyte loss in murine models of MS, the effect of copper on T cell function and pathogenicity in MS are unclear. We demonstrate that deletion of Slc31a1 in CD4+ T cells decreased intracellular copper levels, disrupting mitochondrial respiration and rewiring metabolism. These changes altered the epigenetic landscape of pTH17 cells by impairing DNA demethylation capacity, leading to hypermethylated DNA and altered chromatin accessibility at key binding sites for AP-1 transcription factors essential for pTH17 differentiation. As a result, CTR1-deficient T cells showed defective differentiation into pTH17 cells, with decreased production of IL-17A and expression of TH17 signature genes, while the differentiation of other CD4+ T cell subsets remained largely unaffected. Moreover, T cell-specific deletion of Slc31a1 protected mice from central nervous system (CNS) inflammation in the experimental autoimmune encephalomyelitis (EAE) model of MS by suppressing clonal expansion of autoreactive CD4+ T cells. These findings establish copper as a critical regulator of pTH17 differentiation and function, revealing a previously unknown molecular link between copper homeostasis, metabolism and epigenetic regulation governing pTH17-mediated autoimmunity.

immunology↗

Fetal-intrinsic antiviral mechanisms emerge over the course of gestation

Congenital viral infections have variable effects on pregnancy outcomes with implications for maternal and fetal health. However, the maternal and fetal immune mechanisms that emerge over the course of gestation to determine protective or pathological outcomes remain poorly understood. Here, we use the emerging congenital pathogen Oropouche virus (OROV) to examine gestational stage-dependent differences in maternal and fetal outcomes in a mouse model of congenital infection. Pregnant mice (dams) infected during early gestation resist severe OROV disease, whereas mid-gestation-infected dams succumb to infection. In contrast, fetal pathology is substantial following early gestation infection but limited following infection during mid-gestation, revealing discordant maternal and fetal susceptibility across gestation. Mid-gestation fetal tissues effectively restricted vertical transmission compared to early gestation fetal tissues, corresponding with reduced fetal pathology. Moreover, both placental and fetal tissue cleared OROV RNA over the course of infection, independent of gestational stage, and failure to clear viral RNA was associated with severe fetal pathology. Spatial analysis of early gestation implantation sites further revealed distinct regional susceptibility to OROV infection across the maternal-fetal interface. We identified potential instances of placental-independent vertical transmission via direct fetal contact with highly infected regions of the contralateral maternal uterus. Finally, we uncovered an unexpected mechanism by which type I interferon signaling contributes to inter-fetal immune crosstalk to restrict both OROV vertical transmission and pathology. Together, these findings establish the fetus as an active participant in antiviral defense and reveal previously unrecognized mechanisms by which fetal-intrinsic antiviral immune responses limit congenital viral infection and disease.

immunology↗

Interferon lambda drives immunological maturation in the infant lung and protects against lethal Bordetella pertussis infection

Serious pertussis infections disproportionately affect infants but the biological basis for this age-dependent susceptibility remains unclear. Infant mouse models recapitulate features of severe human infant pertussis. We investigated the role of interferon lambda (IFN-{lambda}), a key regulator of mucosal immunity, in Bordetella pertussis infection of infant mice. While infected adult mice upregulate lung IFN-{lambda}, infant mice inoculated at P7 fail to upregulate IFN-{lambda} and succumb to infection. We hypothesized that failure to produce IFN-{lambda} during infection represents a critical immunological deficit in infant mice, and that restoring IFN-{lambda} signaling would improve survival outcomes. Whereas wild-type mice gained complete protection from lethal B. pertussis infection by P10, mice lacking the IFN-{lambda} receptor component IFNLR1 did not achieve full protection until P21. Loss of IFNLR1 was associated with enhanced bacterial dissemination to systemic organs. Infant mice possessed a functional IFN-{lambda} receptor in the lungs but failed to upregulate IFN-{lambda} during infection, and supplementing IFN-{lambda} exogenously extended survival. RNA sequencing of lung tissue from infected and uninfected wild-type and IFNLR1-deficient mice inoculated at different ages identified an immune transcriptional framework distinguishing susceptible from resistant animals at a systems level and revealed IFN-{lambda} signaling as a critical driver of immunological maturation in the infant lung. Infected infant IFNLR1-deficient mice had dysregulated immune cell recruitment to the lungs, indicating a quantitatively expanded but qualitatively impaired response. These findings demonstrate that IFN-{lambda} affects immune maturation accounting for a critical window of age-dependent resistance to lethal pertussis with novel therapeutic possibilities for human infants with this disease.

immunology↗